Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men

Clinical Endocrinology

Volumn 78, Issue 5, 2013, Pages 752-759

  Yeap, B B ^a,b   Paul Chubb, S A ^a,c   Lopez, Derrick ^d   Ho, K K Y ^e   Hankey, Graeme J ^a   Flicker, Leon ^a,e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

AGED; ARTICLE; CLIMBING; COMORBIDITY; FATIGUE; FRAIL ELDERLY; FRAIL SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; WALKING DIFFICULTY; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; FRAIL ELDERLY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; TESTOSTERONE;

EID: 84876135896     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12052     Document Type: Article

References (35)

1. Fried, L.P., Tangen, C.M., Walston, J., et al,. (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 56, M146-M156.
2. Ahmed, N., Mandel, R., &, Fain, M.J., (2007) Frailty: an emerging geriatric syndrome. American Journal of Medicine, 120, 748-753.
3. Abellan van Kan, G., Rolland, Y., Bergman, H., et al,. (2008) The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. Journal of Nutrition, Health and Aging, 12, 29-37.
4. Perrini, S., Laviola, L., Carreira, M.C., et al,. (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. Journal of Endocrinology, 205, 201-210.
5. Sherlock, M., &, Toogood, A.A., (2007) Aging and the growth hormone/insulin like growth factor-I axis. Pituitary, 10, 189-203.
6. Ohlsson, C., Mohan, S., Sjogren, K., et al,. (2009) The role of liver-derived insulin-like growth factor-I. Endocrine Reviews, 30, 494-535.
7. Juul, A., (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Research, 13, 113-170.
8. Kotronen, A., Lewitt, M., Hall, K., et al,. (2008) Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. Journal of Clinical Endocrinology and Metabolism, 93, 4867-4872.
9. Cappola, A.R., Xue, Q.-L., &, Fried, L.P., (2009) Multiple hormone deficiencies in anabolic hormones are found in frail older women: The Women's Health and Aging Studies. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 64, A243-A248.
10. Leng, S.X., Hung, W., Cappola, A.R., et al,. (2009) White blood cell counts, insulinlike growth factor-1 levels, and frailty in community-dwelling older women. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 64, A499-A502.
11. Yeap, B.B., Chubb, S.A.P., Ho, K.K.Y., et al,. (2010) Insulin-like growth factor-I and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. European Journal of Endocrinology, 162, 249-257.
12. Tracz, M.J., Sideras, K., Boloña, E.R., et al,. (2006) Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism, 91, 2011-2016.
13. Hyde, Z., Flicker, L., Almeida, O.P., et al,. (2010) Low free testosterone predicts frailty in older men. The Health in Men Study. Journal of Clinical Endocrinology and Metabolism, 95, 3165-3172.
14. Barzilay, J.I., Blaum, C., Moore, T., et al,. (2007) Insulin resistance and inflammation as precursors of frailty. The Cardiovascular Health Study. Archives of Internal Medicine, 167, 635-641.
15. Norman, P.E., Flicker, L., Almeida, O.P., et al,. (2009) Cohort profile: The Health in Men Study (HIMS). International Journal of Epidemiology, 38, 48-52.
16. Ware, J.E., Snow, K.K., Kosinski, M., et al,. (1993) SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, Boston 3.1-3.22.
17. Holman, C.D., Bass, A.J., Rouse, I.L., et al,. (1999) Population-based linkage of health records in Western Australia: development of a health services research linked database. Australian and New Zealand Journal of Public Health, 23, 453-459.
18. Yeap, B.B., Almeida, O.P., Hyde, Z., et al,. (2007) In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. European Journal of Endocrinology, 156, 585-594.
19. Giovannini, S., Marzetti, E., Borst, S.E., et al,. (2008) Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mechanisms of Ageing and Development, 129, 593-601.
20. Taaffe, D.R., Pruitt, L., Reim, J., et al,. (1994) Effect of recombinant growth hormone on the muscle strength response to resistance exercise in elderly men. Journal of Clinical Endocrinology and Metabolism, 79, 1361-1366.
21. Liu, H., Bravata, D.M., Olkin, I., et al,. (2007) Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 146, 104-115.
22. Juul, A., Scheike, T., Davidsen, M., et al,. (2002) Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease. A population-based case-control study. Circulation, 106, 939-944.
23. Johnsen, S.P., Hundborg, H.H., Sorensen, H.T., et al,. (2005) Insulin-like growth factor (IGF) I, -II and IGF binding protein-3 and risk of ischemic stroke. Journal of Clinical Endocrinology and Metabolism, 90, 5937-5941.
24. Vasan, R.S., Sullivan, L.M., D'Agostino, R.B., et al,. (2003) Serum insulin-like growth factor 1 and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Annals of Internal Medicine, 139, 642-648.
25. Laughlin, G.A., Barrett-Connor, E., Criqui, M.H., et al,. (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular mortality in older adults: the Rancho Bernardo study. Journal of Clinical Endocrinology and Metabolism, 89, 114-120.
26. Brugts, M.P., van den Beld, A.W., Hofland, L.J., et al,. (2008) Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. Journal of Clinical Endocrinology and Metabolism, 93, 2515-2522.
27. Burgers, A.M.G., Biermasz, N.R., Schoones, J.W., et al,. (2011) Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. Journal of Clinical Endocrinology and Metabolism, 96, 2912-2920.
28. Yeap, B.B., Chubb, S.A.P., McCaul, K.A., et al,. (2011) Associations of Insulin-like Growth Factor-I and its binding proteins 1 and 3 with all-cause and cardiovascular mortality in older men. The Health in Men Study. European Journal of Endocrinology, 164, 715-723.
29. Wheatcroft, S.B., &, Kearney, M.T., (2009) IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends in Endocrinology and Metabolism, 20, 153-162.
30. Harrela, M., Qiao, Q., Koistinen, R., et al,. (2002) High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Hormone and Metabolic Research, 34, 144-149.
31. Hu, D., Pawlikowska, L., Kanaya, A., et al,. (2009) Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study. Journal of the American Geriatric Society, 57, 1213-1218.
32. Travison, T.G., Nguyen, A.H., Naganathan, V., et al,. (2011) Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the Concord Health and Ageing in Men Project. Journal of Clinical Endocrinology and Metabolism, 96, 2464-2474.
33. Giannoulis, M.G., Sonksen, P.H., Umpleby, M., et al,. (2006) The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 91, 477-484.
34. Sattler, F.R., Castaneda-Sceppa, C., Binder, E.F., et al,. (2009) Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology and Metabolism, 94, 1991-2001.
35. Grossmann, M., (2011) Low testosterone in men with Type 2 diabetes: significance and treatment. Journal of Clinical Endocrinology and Metabolism, 96, 2341-2353.